Review of Well Health Technologies

APR 25, 2024 - WELL is one of the main serial acquirers that operates in the healthcare market in Canada. WELL has been an active user of debt and equity issuance to implement its acquisitive growth strategy, which could be potentially a risk for dilution or unsustainable leverage level. The guidance for FY2024 revenue growth is impressive, indicating a healthy growth profile. The low valuation multiple relative to historical averages and its peer group is also appealing for a long-term hold here. We think investors could do well owning WELL over the next three to five years as the company improves profitability and the market re-rates its valuation, we are maintaining our rating of ‘B+’.

Download Report

WELL Health Technologies Corp. (WELL)

Q: Bit confused on WELL. In one response, it says it was a solid quarter with no negative comments. Management re-iterated guidance. In another response, issues raised about debt etc and it's rated a hold. Stock shot up in the morning and then gradually declined into a loss. Can you ofer an explanation on what's happening with WELL. Was the quarter encouraging or not.

Read Answer Asked on May 14, 2025

Q: Hi there, wouldn't it be worthwhile for some to takeover WELL now, by paying a real good premium to todays price and yet... still scoop up WELL on the cheap, based on its future potential and better execution with new management/board?

If so, who do you feel would want to take over WELL?

What would be a good takeover price based on Q1 results and 2025 forward guidance?

Thanks!

Read Answer Asked by Hussein on May 15, 2025

Q: These 4 stocks , held in roughly equal amounts, constitute my TFSA , which holds my riskier , growthier companies. It’s early yet but could you give me 3 companies to review and follow before the next TFSA contribution.
Also, your choice of either PXT or TSU as potential picks. Thanks Derek

Read Answer Asked by Derek on May 15, 2025